Year |
Citation |
Score |
2013 |
Wu H, Liu Z, Ling G, Lawrence D, Ding X. Transcriptional suppression of CYP2A13 expression by lipopolysaccharide in cultured human lung cells and the lungs of a CYP2A13-humanized mouse model. Toxicological Sciences : An Official Journal of the Society of Toxicology. 135: 476-85. PMID 23884085 DOI: 10.1093/Toxsci/Kft165 |
0.571 |
|
2012 |
Wei Y, Wu H, Li L, Liu Z, Zhou X, Zhang QY, Weng Y, D'Agostino J, Ling G, Zhang X, Kluetzman K, Yao Y, Ding X. Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 1144-50. PMID 22397853 DOI: 10.1124/Dmd.112.044826 |
0.608 |
|
2009 |
Wu H, Zhang X, Ling G, D'Agostino J, Ding X. Mechanisms of differential expression of the CYP2A13 7520C and 7520G alleles in human lung: allelic expression analysis for CYP2A13 heterogeneous nuclear RNA, and evidence for the involvement of multiple cis-regulatory single nucleotide polymorphisms. Pharmacogenetics and Genomics. 19: 852-63. PMID 20431511 DOI: 10.1097/Fpc.0B013E3283313Aa5 |
0.586 |
|
2008 |
D'Agostino J, Zhang X, Wu H, Ling G, Wang S, Zhang QY, Liu F, Ding X. Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 2316-23. PMID 18669584 DOI: 10.1124/Dmd.108.022822 |
0.596 |
|
2007 |
Ling G, Wei Y, Ding X. Transcriptional regulation of human CYP2A13 expression in the respiratory tract by CCAAT/enhancer binding protein and epigenetic modulation. Molecular Pharmacology. 71: 807-16. PMID 17148654 DOI: 10.1124/Mol.106.031104 |
0.59 |
|
2007 |
D'Agostino J, Zhang X, Wu H, Ling G, Zhang Q, Ding X. Characterization of CYP2A13*2, a variant cytochrome P450 allele associated with decreased incidences of lung adenocarcinoma in smokers The Faseb Journal. 21. DOI: 10.1096/fasebj.21.5.a415-b |
0.466 |
|
2005 |
Zhang X, Zhang QY, Liu D, Su T, Weng Y, Ling G, Chen Y, Gu J, Schilling B, Ding X. Expression of cytochrome p450 and other biotransformation genes in fetal and adult human nasal mucosa. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 1423-8. PMID 16014766 DOI: 10.1124/Dmd.105.005769 |
0.63 |
|
2004 |
Ling G, Gu J, Genter MB, Zhuo X, Ding X. Regulation of cytochrome P450 gene expression in the olfactory mucosa. Chemico-Biological Interactions. 147: 247-58. PMID 15135081 DOI: 10.1016/J.Cbi.2004.02.003 |
0.613 |
|
2004 |
Ling G, Hauer CR, Gronostajski RM, Pentecost BT, Ding X. Transcriptional regulation of rat CYP2A3 by nuclear factor 1: identification of a novel NFI-A isoform, and evidence for tissue-selective interaction of NFI with the CYP2A3 promoter in vivo. The Journal of Biological Chemistry. 279: 27888-95. PMID 15123731 DOI: 10.1074/Jbc.M403705200 |
0.508 |
|
2001 |
Xie Y, Madelian V, Zhang J, Ling G, Ding X. Activation of the NPTA element of the CYP2A3 gene by NFI-A2, a nasal mucosa-selective nuclear factor 1 isoform. Biochemical and Biophysical Research Communications. 289: 1225-8. PMID 11741324 DOI: 10.1006/bbrc.2001.6084 |
0.489 |
|
Show low-probability matches. |